Back
Catalyst Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
CPRX
Catalyst Pharmaceuticals, Inc.
Last Price:
$23.75
Seasonality Move:
6.75%
7 Day Trial
ALL ACCESS PASS
$
7
Catalyst Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 38.3% based on the past 19 years of stock performance.
-
Catalyst Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
-
Is Catalyst Pharmaceuticals, Inc. Stock Undervalued?The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $23.74. The Score for CPRX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Catalyst Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 38.3% based on the past 19 years of stock performance.
Catalyst Pharmaceuticals, Inc. Stock Rating
Buy
80
Catalyst Pharmaceuticals, Inc. (CPRX)
is a Buy
Is Catalyst Pharmaceuticals, Inc. overpriced?
-
Catalyst Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Catalyst Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com
52-Week Data
52-Week High:
26.58
52-Week Low:
19.05
Prediction Charts
Market Cap:
2.9B
Price in USD:
23.74
Volume:
2.2M
Beta:
1.05
Technical Analysis
SMA50:
22.25
SMA100:
21.28
SMA200:
22.15
52-Wk Change:
10.62%
Stock Predictions
-
Is Catalyst Pharmaceuticals, Inc. stock public?Yes, Catalyst Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Catalyst Pharmaceuticals, Inc. stock quote today?The Catalyst Pharmaceuticals, Inc. stock price is 23.74 USD today.
-
How to buy Catalyst Pharmaceuticals, Inc. stock online?You can buy Catalyst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 22.79 | 22.62 | 22.93 | 22.42 |
| Dec-3 | 22.82 | 23.10 | 23.24 | 22.66 |
| Dec-4 | 22.85 | 23.08 | 23.22 | 22.56 |
| Dec-5 | 23.08 | 23.53 | 23.55 | 23.02 |
| Dec-8 | 23.74 | 23.16 | 23.84 | 23.12 |
| Dec-9 | 23.21 | 22.55 | 23.31 | 22.50 |
| Dec-10 | 22.50 | 22.80 | 22.86 | 22.20 |
| Dec-11 | 22.88 | 22.94 | 23.39 | 22.80 |
| Dec-12 | 23.06 | 23.62 | 23.84 | 22.67 |
| Dec-15 | 23.69 | 24.18 | 25.14 | 23.69 |
| Dec-16 | 24.18 | 24.19 | 24.50 | 24.01 |
| Dec-17 | 24.07 | 24.00 | 24.45 | 23.88 |
| Dec-18 | 23.93 | 23.67 | 24.04 | 23.44 |
| Dec-19 | 23.80 | 23.74 | 24.22 | 23.67 |
Catalyst Pharmaceuticals, Inc. Earnings
Catalyst Pharmaceuticals, Inc. Earnings Report: Per Share Catalyst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Catalyst Pharmaceuticals, Inc. Forecast Revenue Growth
Catalyst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.
* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.